{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:56:39Z","timestamp":1787021799775,"version":"build-2736575974"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012395","name":"Canadian Immunization Research Network","doi-asserted-by":"publisher","award":["CNF 151944"],"award-info":[{"award-number":["CNF 151944"]}],"id":[{"id":"10.13039\/501100012395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>In May 2022, an outbreak of mpox emerged in Canada. In June 2022, the province of Ontario began offering first doses of a 2-dose regimen of Modified Vaccinia Ankara\u2013Bavaria Nordic (MVA-BN) to those at high risk of exposure. Second doses became available in September 2022. To help increase dose 2 access and uptake, we sought to understand how individuals who received 2 doses differed from those who received only 1 dose. We conducted a cross-sectional study using population-level data among individuals who received \u22651 dose of MVA-BN between June 6, 2022 and October 31, 2023 in Ontario. We used age-adjusted Poisson regression to examine the association between demographic, social, and economic characteristics; co-morbidities; and proxies for sexual exposure (e.g., bacterial sexually transmitted infection [STI] diagnoses) and proxies for healthcare engagement (e.g., syphilis testing, past receipt of other vaccines) with MVA-BN dose 2 receipt. Among 33,012 individuals with \u22651 MVA-BN dose, 38.2% (12,620) received 2 doses. Receipt of dose 2 versus only dose 1 was associated with region (e.g., higher in Ottawa compared with Toronto [prevalence ratio, PR\u2009=\u20091.08, 95% confidence interval, CI 1.06-1.09]); syphilis testing (\u22654 tests PR\u2009=\u20091.12, 95%CI 1.11-1.14) or receiving a COVID-19, influenza, or other vaccine (PR\u2009=\u20091.12, 95%CI 1.11-1.14) in the year before dose 1; and syphilis testing (\u22654 tests PR\u2009=\u20091.19, 95%CI 1.18-1.20) or bacterial STI diagnoses &gt;3 months after dose 1 (\u22654 diagnoses PR\u2009=\u20091.07, 95% CI 1.05-1.08). Refugees were less likely to get dose 2 versus Canadian-born individuals or long-term immigrants (PR\u2009=\u20090.93, 95%CI 0.91-0.95).Our findings suggest lower healthcare access and\/or engagement may play a role in limiting dose 2 receipt in Ontario. Public messaging around availability and eligibility of second doses, tailored strategies for eligible refugees, increased access outside healthcare venues, and adopting promotion strategies from regions with high uptake, may help increase dose 2 coverage.<\/jats:p>","DOI":"10.1371\/journal.pgph.0005452","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:37:32Z","timestamp":1764182252000},"page":"e0005452","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada"],"prefix":"10.1371","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-2442","authenticated-orcid":true,"given":"Ramandip","family":"Grewal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann N.","family":"Burchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4291-4719","authenticated-orcid":true,"given":"Lindsay","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3219-5995","authenticated-orcid":true,"given":"Evaezi","family":"Okpokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3069-2875","authenticated-orcid":true,"given":"Darrell H. S.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4219-6887","authenticated-orcid":true,"given":"Austin","family":"Zygmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8492-5470","authenticated-orcid":true,"given":"Sharmistha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Buchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Canadian Immunization Research Network (CIRN) Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"pgph.0005452.ref001","author":"National Advisory Committee on Immunization","year":"2024"},{"key":"pgph.0005452.ref002","author":"Public Health Agency of Canada","year":"2024"},{"issue":"25","key":"pgph.0005452.ref003","doi-asserted-by":"crossref","first-page":"126053","DOI":"10.1016\/j.vaccine.2024.06.021","article-title":"Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis","volume":"42","author":"L Pischel","year":"2024","journal-title":"Vaccine"},{"key":"pgph.0005452.ref004","author":"Government of Ontario","year":"2024"},{"key":"pgph.0005452.ref005","author":"Ontario Ministry of Health","year":"2022"},{"key":"pgph.0005452.ref006","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario)","year":"2024"},{"key":"pgph.0005452.ref007","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario)","year":"2025"},{"issue":"7624","key":"pgph.0005452.ref008","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"E von Elm","year":"2007","journal-title":"BMJ"},{"key":"pgph.0005452.ref009","author":"ICES"},{"key":"pgph.0005452.ref010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078243","article-title":"Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial","volume":"386","author":"C Navarro","year":"2024","journal-title":"BMJ"},{"issue":"12","key":"pgph.0005452.ref011","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/aje\/kwac115","article-title":"A Framework for Descriptive Epidemiology","volume":"191","author":"CR Lesko","year":"2022","journal-title":"Am J Epidemiol"},{"key":"pgph.0005452.ref012","volume-title":"Mpox in Ontario: May 1, 2022 to July 31, 2023 [Internet].","author":"Ontario Agency for Health Protection and Promotion (Public Health Ontario)","year":"2023"},{"issue":"27","key":"pgph.0005452.ref013","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2023.05.043","article-title":"Predictors of Mpox vaccine uptake among sexual and gender minority young adults living in Illinois: Unvaccinated vs. double vs. single dose vaccine recipients","volume":"41","author":"MG Curtis","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"pgph.0005452.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-024-00564-1","article-title":"Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis","volume":"4","author":"SK Sulaiman","year":"2024","journal-title":"Commun Med"},{"issue":"15","key":"pgph.0005452.ref015","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.vaccine.2023.02.075","article-title":"Uptake of mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in Vancouver, British Columbia","volume":"41","author":"M Gilbert","year":"2023","journal-title":"Vaccine"},{"issue":"10","key":"pgph.0005452.ref016","doi-asserted-by":"crossref","DOI":"10.3201\/eid3010.240292","article-title":"Mpox epidemiology and vaccine effectiveness, England, 2023","volume":"30","author":"H Charles","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"pgph.0005452.ref017","author":"BC Centre for Disease Control","year":"2024"},{"key":"pgph.0005452.ref018","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"pgph.0005452.ref019","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s10903-022-01337-5","article-title":"COVID-19 pandemic and Immigrants\u2019 elevated health concerns in Canada: Vaccine hesitancy, anticipated stigma, and risk perception of accessing care","volume":"24","author":"S Lin","year":"2022","journal-title":"J Immigr Minor Health"},{"issue":"1","key":"pgph.0005452.ref020","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28156","article-title":"Prevalence and factors related to COVID-19 vaccine hesitancy and unwillingness in Canada: A systematic review and meta-analysis","volume":"95","author":"JM C\u00e9nat","year":"2023","journal-title":"J Med Virol"},{"issue":"46","key":"pgph.0005452.ref021","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1016\/j.vaccine.2020.09.054","article-title":"Interventions to reduce the burden of vaccine-preventable diseases among migrants and refugees worldwide: A scoping review of published literature, 2006\u20132018","volume":"38","author":"NA Charania","year":"2020","journal-title":"Vaccine"},{"issue":"20","key":"pgph.0005452.ref022","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.vaccine.2019.04.001","article-title":"Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature, 2006 to 2016","volume":"37","author":"NA Charania","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"pgph.0005452.ref023","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3390\/vaccines10111965","article-title":"COVID-19 Vaccination in Migrants and Refugees: Lessons Learnt and Good Practices","volume":"10","author":"P Immordino","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"pgph.0005452.ref024","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1080\/21645515.2021.1979379","article-title":"Human papillomavirus (HPV) vaccination across a cascade of knowledge, willingness, and uptake among gay, bisexual, and other men who have sex with men in Canada\u2019s three largest cities","volume":"17","author":"R Grewal","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"pgph.0005452.ref025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/OLQ.0000000000000626","article-title":"Human papillomavirus vaccination among young men who have sex with men and transgender women in 2 US cities, 2012\u20132014","volume":"44","author":"PM Gorbach","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"3","key":"pgph.0005452.ref026","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/lgbt.2014.0028","article-title":"Bundling Human Papillomavirus Vaccination and Rapid Human Immunodeficiency Virus Testing for Young Gay and Bisexual Men","volume":"1","author":"JJ van den Berg","year":"2014","journal-title":"LGBT Health"},{"issue":"5","key":"pgph.0005452.ref027","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1071\/SH23075","article-title":"Mpox knowledge, vaccination and intention to reduce sexual risk practices among men who have sex with men and transgender people in response to the 2022 mpox outbreak: a cross-sectional study in Victoria, Australia","volume":"20","author":"EPF Chow","year":"2023","journal-title":"Sex Health"},{"issue":"7","key":"pgph.0005452.ref028","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/vaccines11071167","article-title":"Mpox Incidence and Vaccine Uptake in Men Who Have Sex with Men and Are Living with HIV in Denmark","volume":"11","author":"A-SW Svartstein","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"pgph.0005452.ref029","first-page":"100712","article-title":"Accessing first doses of mpox vaccine made available in Victoria, Australia","volume":"31","author":"EPF Chow","year":"2023","journal-title":"Lancet Reg Health West Pac"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005452","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:37:37Z","timestamp":1764182257000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0005452"}},"subtitle":[],"editor":[{"given":"Yogesh","family":"Hooda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0005452","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}